MeiraGTx
MGTX
NZ$13.54
Share price
-1.94%
Change (1 day)
62.43%
Change (1 year)
Earnings for MeiraGTx (MGTX)
Earnings in 2025 (TTM): -NZ$0.27 Billion
According to MeiraGTx's latest financial reports the company's current earnings are NZ$34.5 Million. In 2024 the company made an earning of -NZ$0.23 Billion a decrease over its 2023 earnings that were of -NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for MeiraGTx from 2017 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -NZ$0.27 Billion | 15.2% |
| 2024 | -NZ$0.23 Billion | 90.05% |
| 2023 | -NZ$0.12 Billion | -43.22% |
| 2022 | -NZ$0.21 Billion | 57.27% |
| 2021 | -NZ$0.14 Billion | 37.02% |
| 2020 | -NZ$97.08 Million | 5.77% |
| 2019 | -NZ$91.78 Million | -34.34% |
| 2018 | -NZ$0.14 Billion | 168.72% |
| 2017 | -NZ$52.02 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | -NZ$0.2 Billion | -24.05% | Jersey |
 Novavax NVAX | NZ$0.85 B | -430.73% | 🇺🇸 USA |
 Organovo ONVO | -NZ$4.18 Million | -98.39% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -NZ$0.13 Billion | -52.64% | 🇬🇧 UK |